Excessive Daytime Sleepiness Linked to Diet and Hormones: New Study Reveals Key Blood Metabolites

Excessive daytime sleepiness (EDS), a condition impacting nearly one in three Americans, may be strongly influenced by diet and hormone-related metabolites in the blood, according to a groundbreaking study published recently in The Lancet eBioMedicine. Led by researchers at Mass General Brigham and Beth Israel Deaconess Medical Center, the study identified seven key blood metabolites associated with EDS, highlighting novel biological pathways that could pave the way for targeted interventions, including dietary changes and supplement use.

Key Findings: Metabolites Connect Diet, Hormones, and Sleepiness

The study analyzed blood samples from over 6,000 participants enrolled in the Hispanic Community Health Study/Study of Latinos and examined 877 metabolites—small molecules naturally present in the bloodstream that reflect both genetic and environmental factors. Researchers found that higher blood levels of omega-3 and omega-6 fatty acids—nutrients abundant in Mediterranean-style diets rich in fish, nuts, and olive oil—were associated with a lower risk of excessive daytime sleepiness, suggesting these fats may protect against daytime drowsiness.

Conversely, the metabolite tyramine, commonly found in fermented or overripe foods such as aged cheeses, pickled meats, and certain alcoholic beverages, was linked to increased daytime sleepiness, particularly among men. Additionally, steroid hormone metabolites, including progesterone and other sex steroids involved in sleep regulation through mechanisms like melatonin production, were found to correlate with EDS risk, underscoring the influence of hormonal balance on sleep-wake cycles.​

Expert Perspectives and Study Context

Dr. Tariq Faquih, PhD, lead author and postdoctoral fellow at the Division of Sleep and Circadian Disorders at Brigham and Women’s Hospital, explained, “Our findings suggest that both diet and genetics may play an important role in excessive daytime sleepiness. Understanding these biological factors allows us to better identify early signs and explore preventive or therapeutic strategies.”

Supporting experts note the importance of these findings amid the widespread prevalence of EDS, which affects up to 33% of Americans daily and is linked to serious health risks including cardiovascular disease, obesity, and diabetes. “This study adds valuable insight into how what we eat and our hormonal milieu can influence alertness and sleepiness during the day,” noted Dr. Linda Mayo, a sleep medicine specialist not involved in the research. “Intervening on diet or addressing hormonal imbalances may provide new avenues to reduce the burden of excessive sleepiness,” she added.​

The research validation included secondary analyses in diverse cohorts such as the U.S. Multi-Ethnic Study of Atherosclerosis (MESA), the UK Biobank, and Finnish population studies, reinforcing the generalizability of the metabolite-sleepiness associations despite methodological variability in metabolite detection across studies.​

Implications for Public Health and Individuals

With excessive daytime sleepiness linked to impaired cognitive function, higher accident risk, and diminished quality of life, these findings hold practical implications. Incorporating omega-3 and omega-6 rich foods like fatty fish, nuts, and plant oils could be a feasible, non-pharmacological approach to improve daytime alertness for some individuals. Conversely, caution with tyramine-rich fermented foods might be prudent for those susceptible to sleepiness or related migraines.

Furthermore, recognizing the hormonal contributions to EDS—including metabolites related to progesterone and melatonin production—points to potential hormonal targets for intervention, especially in populations with hormone fluctuations such as women experiencing menstrual cycle-related sleep disturbances.

Balanced Reporting and Study Limitations

While promising, the study’s observational design means causality cannot be definitively established, and further clinical trials are needed to test whether modifying diet or supplementing specific metabolites can reduce EDS symptoms. The metabolite identification methods varied among the validation cohorts, which could limit the consistency of findings.

Moreover, EDS is a multifactorial condition influenced by sleep disorders, psychiatric conditions, medication use, and comorbidities, underscoring that diet and hormones are part of a broader etiological landscape.

Conclusion

This landmark study reveals intricate biological links between diet, hormonal metabolites, and excessive daytime sleepiness, sharing critical insights into a common yet underrecognized public health problem. Future research aimed at intervention trials may herald novel treatments, empowering individuals and clinicians to combat daytime drowsiness through personalized dietary and hormonal strategies.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References